| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| July 24, 2026 | ±3.3% | +1.0% | over-priced |
| April 24, 2026 | ±3.5% | -3.0% | over-priced |
| October 24, 2025 | ±3.9% | -0.1% | over-priced |
| July 25, 2025 | ±3.9% | -0.1% | over-priced |
| April 24, 2025 | ±2.7% | +1.2% | over-priced |
| October 24, 2024 | ±3.0% | +1.1% | over-priced |
| July 25, 2024 | ±2.0% | +1.6% | over-priced |
| April 26, 2024 | ±3.2% | -1.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.80 | $11.2B | $3.0B |
| Q1 FY2026 | $1.56 | $10.1B | $2.6B |
| Q4 FY2025 | $1.37 | $10.4B | $2.3B |
| Q3 FY2025 | $2.23 | $10.8B | $3.6B |
Philip Morris International Inc. (PM) reports in 110 days, with the next report estimated for November 15, 2026. Across the last 8 reports, options priced an average ±3.2% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced PM's earnings risk. Fundamentals into the print: EPS down 7.7% year-over-year, revenue up 10.4%. QuantLogix's live 5-factor engine currently reads PM as a strong buy at 92/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →